P

Pennant Group Inc
F:1ZU

Watchlist Manager
Pennant Group Inc
F:1ZU
Watchlist
Price: 25.8 EUR -1.53% Market Closed
Market Cap: €775.2m

Pennant Group Inc
Investor Relations

Pennant Group runs local home health, hospice, and senior living businesses. Its agencies send nurses, therapists, aides, and caregivers into patients’ homes or to senior living communities, and its hospice teams provide end-of-life care and support for families. In senior living, it also helps manage and operate communities that provide housing, meals, and daily assistance for older adults. Its main customers are seniors, patients recovering from illness or surgery, and families who need ongoing care support. Pennant gets paid mostly through reimbursement from Medicare, Medicaid, commercial health plans, and private-pay residents or families. That means it sits in the middle of the care chain: it turns referrals from doctors, hospitals, and families into hands-on care delivered by local teams. What makes the business model different is that it is built around many smaller, community-based care operations rather than one large hospital or clinic network. Pennant’s role is to manage these local agencies, keep caregivers staffed, and coordinate care across settings. In plain terms, it sells essential services that help people stay at home longer, recover after a health event, or receive hospice care with dignity.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
May 7, 2026
AI Summary
Q1 2026

Strong quarter: Pennant reported revenue of $285.4 million, up 36%, with adjusted diluted EPS of $0.32, up 18.5%, and management said results were strong across both segments.

Integration on track: The Southeast transition from UnitedHealthcare/Amedisys is progressing through the planned waves, with management saying census recovered above acquisition levels and the work is still expected to finish by the end of the third quarter.

Margins improved: Same-store Home Health and Hospice margin prior to NCI improved 110 basis points year over year to 17.2%, even with wage pressure and transition costs.

Guidance stance: Management did not raise guidance after Q1, but said they are pointing investors to the upper end of the range and will reassess after Q2.

Active M&A: Senior Living added 4 acquisitions after quarter end, and management said it expects to remain active in both Senior Living and tuck-in Home Health/Hospice deals.

Positive policy backdrop: Pennant highlighted a proposed 2.4% hospice rate increase and said efforts to crack down on fraud, waste and abuse could create share gains for compliant operators like Pennant.

Key Financials
Revenue
$285.4 million
Adjusted EBITDA
$21.7 million
Adjusted EBITDA prior to NCI
$23.5 million
Adjusted diluted earnings per share
$0.32
GAAP revenue
$285.4 million
GAAP net income
$8.5 million
GAAP diluted earnings per share
$0.24
Home Health and Hospice revenue
$229.1 million
Home Health and Hospice adjusted EBITDA
$33.6 million
Home Health and Hospice adjusted EBITDA prior to NCI
$35.4 million
Total Home Health admissions
30,721
Medicare Home Health admissions
13,303
Same-store admission growth
5.8%
Same-store Medicare admission growth
9.2%
Hospice average daily census
5,199
Same-store Hospice average daily census
3,952
Same-store segment adjusted EBITDA margin prior to NCI
17.2%
Overall segment adjusted EBITDA margin prior to NCI
15.5%
Hospice rate increase
2.4%
Senior Living revenue
$56.3 million
Senior Living adjusted EBITDA
$6.4 million
Senior Living segment adjusted EBITDA margin
11.8%
Same-store occupancy
81%
All-store occupancy
78.6%
Revolving line of credit outstanding
$72 million
Term loan outstanding
$98.8 million
Total credit facility outstanding
$170.8 million
Cash on hand
$4.9 million
Net debt to adjusted EBITDA ratio
1.93x
Cash flows used in operations
$3.4 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Brent J. Guerisoli
CEO & Director
No Bio Available
Mr. John J. Gochnour
President & COO
No Bio Available
Ms. Lynette B. Walbom CPA
Chief Financial Officer
No Bio Available
Mr. Kirk S. Cheney
General Counsel & Corporate Secretary
No Bio Available
Mr. Jason P. Steik
Chief Clinical Officer
No Bio Available
Mr. Brian W. Wayment
President of Cornerstone Healthcare
No Bio Available

Contacts

Address
IDAHO
Eagle
1675 E Riverside Dr Ste 150
Contacts
+12089576025.0
www.pennantgroup.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett